tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Biren Amin, 30 are a HOLD (17.65%), 139 are a BUY (81.76%), 1 are a SELL (0.59%).
Analyst Biren Amin, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 52.14% that have a potential upside of 32.72% achieved within 215 days. Previously, Biren Amin worked at JEFFERIES.
Biren Amin’s has documented 341 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 16-Jun-2025.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$25
$20.24 (425.21%)
26 days ago
(04-Jun-2025)
3/10 (30%)
$19.37 (344.05%)
285
Buy
$11
$6.24 (131.09%)
$18
7 months 12 days ago
(18-Nov-2024)
1/3 (33.33%)
$8.37 (318.25%)
31
Buy
$5
$0.24 (5.04%)
$7.85
1 years 3 months 12 days ago
(18-Mar-2024)
2/2 (100%)
$-5.59 (-52.79%)
207
Buy
$8.15
$3.39 (71.22%)
$8.15
2 years 3 months 2 days ago
(28-Mar-2023)
3/3 (100%)
$-20.9 (-71.94%)
465
Buy
$6.87
$5.74 (507.96%)
4 years 3 months 14 days ago
(16-Mar-2021)
0/1 (0%)
$3.72 (118.10%)
Which stock is Biren Amin is most bullish on?
Which stock is Biren Amin is most reserved on?
What Year was the first public recommendation made by Biren Amin?
